The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000162.5(GCK):c.864-1G>C

CA367400275

1700683 (ClinVar)

Gene: GCK (HGNC:2645)
Condition: monogenic diabetes (MONDO:0015967)
Inheritance Mode: Semidominant inheritance
UUID: c3958899-d5c4-4e45-8cd5-3a8344defd55
Approved on: 2025-11-24
Published on: 2025-11-26

HGVS expressions

NM_000162.5:c.864-1G>C
NM_000162.5(GCK):c.864-1G>C
NC_000007.14:g.44146619C>G
CM000669.2:g.44146619C>G
NC_000007.13:g.44186218C>G
CM000669.1:g.44186218C>G
NC_000007.12:g.44152743C>G
NG_008847.1:g.47805G>C
NG_008847.2:g.56552G>C
ENST00000395796.8:c.*862-1G>C
ENST00000616242.5:c.854-1G>C
ENST00000683378.1:n.89G>C
ENST00000345378.7:c.867-1G>C
ENST00000403799.8:c.864-1G>C
ENST00000671824.1:c.927-1G>C
ENST00000673284.1:c.864-1G>C
ENST00000345378.6:c.867-1G>C
ENST00000395796.7:c.861-1G>C
ENST00000403799.7:c.864-1G>C
ENST00000437084.1:c.813-1G>C
ENST00000473353.1:n.162-1G>C
ENST00000616242.4:c.861-1G>C
NM_000162.3:c.864-1G>C
NM_033507.1:c.867-1G>C
NM_033508.1:c.861-1G>C
NM_000162.4:c.864-1G>C
NM_001354800.1:c.864-1G>C
NM_001354801.1:c.8G>C
NM_033507.2:c.867-1G>C
NM_033508.2:c.861-1G>C
NM_033507.3:c.867-1G>C
NM_033508.3:c.861-1G>C
More

Pathogenic

Met criteria codes 5
PS4_Moderate PP4 PS1_Supporting PVS1 PM2_Supporting
Not Met criteria codes 1
PP1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Monogenic Diabetes Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for GCK Version 3.1.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Monogenic Diabetes VCEP
The c.864-1G>C variant in the glucokinase gene, GCK, is predicted to remove a canonical splice acceptor site in NM_000162.5. This variant is predicted to cause an in-frame deletion of biologically-relevant exon 8 of 10, a region important for protein function (PVS1). This variant has an incomputable gnomAD v4.1.0 Grpmax filtering allele frequency due to no more than 1 copy in any subpopulation, thereby meeting the ClinGen MDEP threshold criteria for PM2_Supporting (Grpmax FAF <= 0.000003) (PM2_Supporting). This variant was identified in five unrelated individuals with hyperglycemia (PS4_Moderate; PMID: 25850297, 36208030, 20337973, internal lab contributors). Additionally, at least one of these individuals had a clinical history highly specific for GCK-hyperglycemia (fasting glucose 5.5-8 mmol/L and HbA1c 5.6 - 7.6%) (PP4; internal lab contributors). This variant segregated with diabetes with two informative meioses in a single family; however, this does not meet the thresholds for PP1 set by the ClinGen MDEP (PMID: 27236918, internal lab contributors). The c.864-1G>A variant at the same canonical nucleotide has been classified as pathogenic for monogenic diabetes by the ClinGen MDEP, and c.864-1G>C has a similar predicted impact by Splice AI (PS1_Supporting). In summary, c.864-1G>C meets the criteria to be classified as pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 3.1.0, approved 10/10/2025): PVS1, PS1_Supporting, PS4_Moderate, PM2_Supporting, PP4.
Met criteria codes
PS4_Moderate
This variant was identified in five unrelated individuals with hyperglycemia (PS4_Moderate; PMID: 25850297, 36208030, 20337973, internal lab contributors).
PP4
This variant was identified in an individual with a clinical history highly specific for GCK-hyperglycemia (fasting glucose 5.5-8 mmol/L and HbA1c 5.6 - 7.6%) (PP4; internal lab contributors).
PS1_Supporting
The c.864-1G>A variant at the same canonical nucleotide has been classified as pathogenic for monogenic diabetes by the ClinGen MDEP, and c.864-1G>C has a similar predicted impact by Splice AI (PS1_Supporting).
PVS1
This variant is predicted to cause an in-frame deletion of biologically-relevant exon 8 of 10, a region important for protein function (PVS1).
PM2_Supporting
This variant has an incomputable gnomAD v4.1.0 Grpmax filtering allele frequency due to no more than 1 copy in any subpopulation, thereby meeting the ClinGen MDEP threshold criteria for PM2_Supporting (Grpmax FAF <= 0.000003) (PM2_Supporting).
Not Met criteria codes
PP1
This variant segregated with diabetes with two informative meioses in a single family; however, this does not meet the thresholds for PP1 set by the ClinGen MDEP (PMID: 27236918, internal lab contributors).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.